Combination Anthelmintic Treatment for Persistent Ancylostoma caninum Ova Shedding in Greyhounds

J Am Anim Hosp Assoc. May/Jun 2019;55(3):160-166. doi: 10.5326/JAAHA-MS-6904. Epub 2019 Mar 14.

Abstract

Ancylostoma caninum is a nematode of the canine gastrointestinal tract commonly referred to as hookworm. This study involved eight privately owned adult greyhounds presenting with persistent A. caninum ova shedding despite previous deworming treatments. The dogs received a combination treatment protocol comprising topical moxidectin, followed by pyrantel/febantel/praziquantel within 24 hr. At 7-10 days posttreatment, a fecal examination monitored for parasite ova. Dogs remained on the monthly combination treatment protocol until they ceased shedding detectable ova. The dogs then received only the monthly topical moxidectin maintenance treatment. The dogs remained in the study for 5-14 mo with periodical fecal examinations performed. During the study, three dogs reverted to positive fecal ova status, with two being associated with client noncompliance. Reinstitution of the combination treatment protocol resulted in no detectable ova. Use of monthly doses of combination pyrantel, febantel and moxidectin appears to be an effective treatment for nonresponsive or persistent A. caninum ova shedding. Follow-up fecal examinations were important for verifying the presence or absence of ova shedding despite the use of anthelmintic treatment. Limitations of the current study include small sample size, inclusion of only privately owned greyhounds, and client compliance with fecal collection and animal care.

Publication types

  • Clinical Trial, Veterinary

MeSH terms

  • Ancylostoma*
  • Ancylostomiasis / drug therapy
  • Ancylostomiasis / veterinary*
  • Animals
  • Anthelmintics / therapeutic use
  • Dog Diseases / drug therapy*
  • Dogs
  • Drug Combinations
  • Drug Therapy, Combination
  • Feces / parasitology

Substances

  • Anthelmintics
  • Drug Combinations